Cargando…
Direct activation of the fibroblast growth factor-21 pathway in overweight and obese cats
INTRODUCTION: Feline obesity is common, afflicting ~25–40% of domestic cats. Obese cats are predisposed to many metabolic dyscrasias, such as insulin resistance, altered blood lipids, and feline hepatic lipidosis. Fibroblast Growth Factor-21 (FGF21) is an endocrine hormone that mediates the fat-live...
Autores principales: | Brinker, Emily J., Towns, T. Jordan, Watanabe, Rie, Ma, Xiaolei, Bashir, Adil, Cole, Robert C., Wang, Xu, Graff, Emily C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900002/ https://www.ncbi.nlm.nih.gov/pubmed/36756310 http://dx.doi.org/10.3389/fvets.2023.1072680 |
Ejemplares similares
-
Owner and Cat-Related Risk Factors for Feline Overweight or Obesity
por: Wall, Meredith, et al.
Publicado: (2019) -
Effect of mineral oil as a lubricant to collect feces from cats for microbiome studies
por: Ma, Xiaolei, et al.
Publicado: (2022) -
Whole-Genome Shotgun Metagenomic Sequencing Reveals Distinct Gut Microbiome Signatures of Obese Cats
por: Ma, Xiaolei, et al.
Publicado: (2022) -
Diagnostic Criteria for Obesity Disease in Cats
por: Okada, Yuki, et al.
Publicado: (2019) -
Fibroblast growth factor-21 (FGF21) analogs as possible treatment options for diabetes mellitus in veterinary patients
por: Corbee, Ronald J., et al.
Publicado: (2023)